BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.810
-0.020 (-1.09%)
At close: Mar 28, 2025, 4:00 PM
1.822
+0.012 (0.65%)
After-hours: Mar 28, 2025, 7:56 PM EDT
BioRestorative Therapies Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioRestorative Therapies stock has a target of 18, which predicts an increase of 894.48% from the current stock price of 1.81.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 14, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for BioRestorative Therapies is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +894.48% | Aug 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +728.73% | Jun 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +728.73% | Aug 14, 2023 |
| Roth Capital | Roth Capital | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +728.73% | Dec 7, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +231.49% | Sep 28, 2022 |
Financial Forecast
Revenue This Year
849.66K
from 145.80K
Increased by 482.76%
Revenue Next Year
2.65M
from 849.66K
Increased by 212.24%
EPS This Year
-1.25
from -2.47
EPS Next Year
-1.48
from -1.25
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 900,900 | 3.2M | 3.7M | |||
| Avg | 849,660 | 2.7M | 3.2M | |||
| Low | 791,840 | 2.2M | 2.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 517.9% | 270.7% | 38.5% | |||
| Avg | 482.8% | 212.2% | 20.2% | |||
| Low | 443.1% | 153.9% | 1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.29 | -0.90 | -0.87 | |||
| Avg | -1.25 | -1.48 | -1.01 | |||
| Low | -1.21 | -2.00 | -1.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.